bioMerieux SA (BIM) - Product Pipeline Analysis, 2019 Update
June 2019
65
About the Report
About the Report
Summary
bioMerieux SA (bioMerieux), a subsidiary of Institut Merieux SA, develops, manufactures, and markets in vitro diagnostic solutions for hospital and private laboratories. The company offers diagnostic solutions such as systems, reagents, and software for the diagnosis of infectious diseases, cardiovascular diseases, and cancers and identifying microorganisms in pharmaceuticals, cosmetics, and agri-food products. It offers microbiology products, immunoassays, molecular biology tests, and other solutions for clinical applications and industrial microbiological control solutions for the food, biopharmaceutical and cosmetics industries; veterinary diagnostic laboratories; and blood banks. bioMerieux also provides solutions for the enumeration of bacterial flora which indicate the quality of food products. The company distributes its products directly and also through a network of distributors across the world. bioMerieux is headquartered in Marcy l'Etoile, France.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company bioMerieux SA
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Products
Products
bioMerieux SA, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies
Companies
Siemens Healthineers AG
Thermo Fisher Scientific Inc
Sysmex Corp
Bio-Rad Laboratories Inc
OpGen Inc
Abbott Laboratories
Danaher Corp
Ortho-Clinical Diagnostics Inc
Eurofins Scientific SE
Becton Dickinson and Co
F. Hoffmann-La Roche Ltd
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
bioMerieux SA Company Overview
bioMerieux SA Company Snapshot
bioMerieux SA Pipeline Products and Ongoing Clinical Trials Overview
bioMerieux SA-Pipeline Analysis Overview
Business Description
bioMerieux SA-Key Facts
bioMerieux SA-Major Products and Services
bioMerieux SA Pipeline Products by Development Stage
bioMerieux SA Pipeline Products Overview
Annexin A3 Prostate Cancer Marker
Annexin A3 Prostate Cancer Marker Product Overview
BacT/ALERT VIRTUO System
BacT/ALERT VIRTUO System Product Overview
BRAF-Breast Cancer Diagnostic Kit
BRAF-Breast Cancer Diagnostic Kit Product Overview
CancerTARGET ID
CancerTARGET ID Product Overview
CancerTREATMENT ID
CancerTREATMENT ID Product Overview
Companion Diagnostic Test-Hormone-Dependent Breast Cancer
Companion Diagnostic Test-Hormone-Dependent Breast Cancer Product Overview
Companion Diagnostic Test-Hormone-Dependent Neuro Endocrine Tumor
Companion Diagnostic Test-Hormone-Dependent Neuro Endocrine Tumor Product Overview
Companion Diagnostic Test-Hormone-Dependent Pituitary Tumor
Companion Diagnostic Test-Hormone-Dependent Pituitary Tumor Product Overview
Companion Diagnostic Test-Hormone-Dependent Prostate Cancer
Companion Diagnostic Test-Hormone-Dependent Prostate Cancer Product Overview
Diagnostic Assay-Prostate Cancer
Diagnostic Assay-Prostate Cancer Product Overview
Diagnostic Test-Abdominal Pain
Diagnostic Test-Abdominal Pain Product Overview
Diagnostic Test-Acute Coronary Syndrome
Diagnostic Test-Acute Coronary Syndrome Product Overview
Diagnostic Test-Antimicrobial Resistance
Diagnostic Test-Antimicrobial Resistance Product Overview
Diagnostic Test-Cerebrovascular Injury
Diagnostic Test-Cerebrovascular Injury Product Overview
Diagnostic Test-Sepsis
Diagnostic Test-Sepsis Product Overview
Diagnostic Test-Tuberculosis
Diagnostic Test-Tuberculosis Product Overview
FilmArray 2.0-Lower Respiratory Tract Panel
FilmArray 2.0-Lower Respiratory Tract Panel Product Overview
FilmArray Direct Sepsis Panel
FilmArray Direct Sepsis Panel Product Overview
FilmArray Febrile Infant Panel
FilmArray Febrile Infant Panel Product Overview
FilmArray STD Panel
FilmArray STD Panel Product Overview
FilmArray Torch-Lower Respiratory Tract Panel
FilmArray Torch-Lower Respiratory Tract Panel Product Overview
iMAG
iMAG Product Overview
NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test
NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test Product Overview
NucliSENS EasyQ Legionella spp Molecular Test
NucliSENS EasyQ Legionella spp Molecular Test Product Overview
NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test
NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test Product Overview
VIDAS-Vitamin D Test
VIDAS-Vitamin D Test Product Overview
VIDAS hsCRP Assay
VIDAS hsCRP Assay Product Overview
Vidas Immunoanalyzer-Nephrocheck
Vidas Immunoanalyzer-Nephrocheck Product Overview
bioMerieux SA-Key Competitors
bioMerieux SA-Key Employees
bioMerieux SA-Key Employee Biographies
bioMerieux SA-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
bioMerieux SA, Recent Developments
Jun 03, 2019: Breast Cancer Index and new data on its power to predict extended endocrine therapy benefit presented at ASCO 2019
May 21, 2019: Biotheranostics announces Lee Newcomer, M.D. to join its board of directors
May 13, 2019: NEPHROCHECK Biomarkers TIMP-2 and IGFBP7 Included in the ERAS Guidelines for Perioperative Care in Cardiac Surgery
Apr 24, 2019: bioMerieux: First-quarter 2019 business review
Apr 16, 2019: Breast Cancer Index now covered by Medicare for a Broader Group of Post-Menopausal Patients considering Extended Endocrine Therapy
Apr 04, 2019: Entasis Therapeutics Initiates Global Phase 3 Pivotal Trial of ETX2514SUL for Patients with Carbapenem-Resistant Acinetobacter Infections
Apr 01, 2019: New reimbursement codes for BIOFIRE FILMARRAY Respiratory and Gastrointestinal Panels
Mar 05, 2019: Breast Cancer Index receives expanded medicare coverage under a new local coverage determination
Feb 27, 2019: bioMerieux-2018 Financial Results
Feb 05, 2019: Entasis Therapeutics announces rapid diagnostic agreement with bioMerieux
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
bioMerieux SA Pipeline Products by Equipment Type
bioMerieux SA Pipeline Products by Development Stage
List of Table
List of Tables
bioMerieux SA Pipeline Products and Ongoing Clinical Trials Overview
bioMerieux SA Pipeline Products by Equipment Type
bioMerieux SA Pipeline Products by Indication
bioMerieux SA, Key Facts
bioMerieux SA, Major Products and Services
bioMerieux SA Number of Pipeline Products by Development Stage
bioMerieux SA Pipeline Products Summary by Development Stage
Annexin A3 Prostate Cancer Marker-Product Status
Annexin A3 Prostate Cancer Marker-Product Description
BacT/ALERT VIRTUO System-Product Status
BacT/ALERT VIRTUO System-Product Description
BRAF-Breast Cancer Diagnostic Kit-Product Status
BRAF-Breast Cancer Diagnostic Kit-Product Description
CancerTARGET ID-Product Status
CancerTARGET ID-Product Description
CancerTREATMENT ID-Product Status
CancerTREATMENT ID-Product Description
Companion Diagnostic Test-Hormone-Dependent Breast Cancer-Product Status
Companion Diagnostic Test-Hormone-Dependent Breast Cancer-Product Description
Companion Diagnostic Test-Hormone-Dependent Neuro Endocrine Tumor-Product Status
Companion Diagnostic Test-Hormone-Dependent Neuro Endocrine Tumor-Product Description
Companion Diagnostic Test-Hormone-Dependent Pituitary Tumor-Product Status
Companion Diagnostic Test-Hormone-Dependent Pituitary Tumor-Product Description
Companion Diagnostic Test-Hormone-Dependent Prostate Cancer-Product Status
Companion Diagnostic Test-Hormone-Dependent Prostate Cancer-Product Description
Diagnostic Assay-Prostate Cancer-Product Status
Diagnostic Assay-Prostate Cancer-Product Description
Diagnostic Test-Abdominal Pain-Product Status
Diagnostic Test-Abdominal Pain-Product Description
Diagnostic Test-Acute Coronary Syndrome-Product Status
Diagnostic Test-Acute Coronary Syndrome-Product Description
Diagnostic Test-Antimicrobial Resistance-Product Status
Diagnostic Test-Antimicrobial Resistance-Product Description
Diagnostic Test-Cerebrovascular Injury-Product Status
Diagnostic Test-Cerebrovascular Injury-Product Description
Diagnostic Test-Sepsis-Product Status
Diagnostic Test-Sepsis-Product Description
Diagnostic Test-Tuberculosis-Product Status
Diagnostic Test-Tuberculosis-Product Description
FilmArray 2.0-Lower Respiratory Tract Panel-Product Status
FilmArray 2.0-Lower Respiratory Tract Panel-Product Description
FilmArray Direct Sepsis Panel-Product Status
FilmArray Direct Sepsis Panel-Product Description
FilmArray Febrile Infant Panel-Product Status
FilmArray Febrile Infant Panel-Product Description
FilmArray STD Panel-Product Status
FilmArray STD Panel-Product Description
FilmArray Torch-Lower Respiratory Tract Panel-Product Status
FilmArray Torch-Lower Respiratory Tract Panel-Product Description
iMAG-Product Status
iMAG-Product Description
NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test-Product Status
NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test-Product Description
NucliSENS EasyQ Legionella spp Molecular Test-Product Status
NucliSENS EasyQ Legionella spp Molecular Test-Product Description
NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test-Product Status
NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test-Product Description
VIDAS-Vitamin D Test-Product Status
VIDAS-Vitamin D Test-Product Description
VIDAS hsCRP Assay-Product Status
VIDAS hsCRP Assay-Product Description
Vidas Immunoanalyzer-Nephrocheck-Product Status
Vidas Immunoanalyzer-Nephrocheck-Product Description
bioMerieux SA, Key Employees
bioMerieux SA, Key Employee Biographies
bioMerieux SA, Subsidiaries
Glossary
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.